MedCity News

Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs

MedCity FemFwd: Employer Strategies for Women’s Health

In this episode, we’re joined by Cheryl Larson, president and CEO of the Midwest Business Group on Health, for our first in-person recording at MedCity News’ recent Bullseye event.

By Marissa Plescia

Health Tech

Two Differing POVs Emerge About the Hinge-Cylinder Deal

Hinge Health’s acquisition of Cylinder expands it into GI care, but experts differ on whether employers will favor convenience or specialized solutions.

By Marissa Plescia

BioPharma, Pharma

Latigo Bio’s IPO Lands $346M for Pipeline of Non-Opioid Pain Drugs

Latigo Biotherapeutics will apply the IPO proceeds toward a pipeline that includes a next-generation non-opioid pain drug ready for pivotal testing. BlossomHill Therapeutics also debuted on the Nasdaq, raising cash for cancer drugs designed to address mutations not covered by currently available therapies.

By Frank Vinluan

Latest Video

Latest News

MedCity Influencers

Why Kidney Care’s Biggest Investment Wave Hasn’t Moved Hospital Costs

The problem may not be the investment. It may be the target of the intervention.

By John Erbey

Opinion

My Wish For Better Care For Americans Living in Rural Areas

A letter to Medicaid Directors, State Leaders, and other invested collaborators who were awarded Rural Health Transformation (RHT) Grant funding.

By Lynda Rowe

BioPharma, Policy, Providers, Legal

The US Capitol Building in Washington DC, at an angle, over some trees. The beautiful dome stretches up into the blue sky with scattered clouds.

Bipartisan Lawmakers Are Fighting HHS’ 340B Rebate Push

A bipartisan group of six senators introduced a bill to reform the 340B drug program, locking in hospitals' use of contract pharmacies and adding new transparency and compliance rules. The legislation would also kill HHS' contested rebate pilot within a year and replace it with a national data clearinghouse to catch duplicate discounts.

By Katie Adams

BioPharma, Pharma

Recovery for Replimune: Accelerated Approval for Cancer Drug Twice Spurned by FDA

Replimune went from an FDA rejection to a resubmission, a positive advisory committee vote, and finally an accelerated regulatory approval for advanced melanoma — all in less than four months. The FDA nod for Replimune’s oncolytic viral therapy, Tudriqev, positions it as a more convenient alternative to an Iovance Biotherapeutics cell therapy that had been the only treatment in this setting.

By Frank Vinluan

Policy

Democratic Senators Urge Withdrawal of Interim Final Rule on Medicaid Work Requirements

Democratic senators are urging CMS to withdraw its Medicaid work requirements rule, arguing it will create administrative burdens and cause eligible beneficiaries to lose coverage.

By Marissa Plescia

MedCity Influencers

The Missing Piece of Preventive Dental Care Lies in the Bite

Historically, prevention has focused on protecting teeth from decay and gum disease. However, long-term oral health is also shaped by how the teeth, muscles, and jaw function together over time.

By Dr. Robert B. Kerstein

MedCity Influencers

illustration of man crossing surreal road, risk concept black and white risk

Healthcare Workplace Violence Prevention Needs Better Visibility Into Risk Signals

Gaps in prevention are not frequently due to a complete lack of information, but instead the fact that organizations don't have a clear way to see how the pieces fit together until after an incident has occurred.

By Brian Stromberg

Events, Health Tech

INVEST Digital Health Conference Returns with Focus on Consumers

Scheduled for October 29 at Pegasus Park in Dallas, the theme of the INVEST Digital Health conference will be consumers in healthcare from d2c diagnostics to GLP-1 drugs and wearables. Register today!

By Stephanie Baum

BioPharma, Pharma

Moderna Gets FDA Approval for mRNA Flu Vaccine, But CDC Input Still Uncertain

The FDA approved Moderna’s flu vaccine mFLUSIVA, a regulatory decision that comes six months after the agency refused to review the mRNA shot and then quickly reversed its position. But a recommendation from a Centers for Disease Control and Prevention advisory committee is key for payer coverage, and that committee has not met all year due to ongoing litigation.

By Frank Vinluan

Consumer / Employer

Report: What Employers Think About ICHRAs

A new survey found that many employers are considering ICHRAs, though concerns about awareness, affordability and the individual insurance market continue to slow adoption.

By Marissa Plescia

Health Services, Policy, Payers

Debunked Episode 29: CMS GLP-1 Drug Pilot Program, RPM Strategy Raise Questions

At MedCity News’ inaugural Bullseye conference in Chicago, Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed recent CMS actions and Mayo Clinic’s former research director, who has filed a complaint against the medical center over how it’s deploying AI.

By Stephanie Baum

MedCity Influencers

Connecting the Dots: How Oral Health Can Enable Whole-Person Care

The industry has made real progress in recognizing that oral health belongs at the center of whole-person care, but intent alone isn’t enough. To translate this vision into something tangible, the industry must invest in infrastructure that makes integration not only possible but scalable.

By Larry Paul

MedCity Influencers

Should You Centralize Cold Chain Fulfillment? Only If You’ve Solved Distribution First

Cold chain is a logistics problem — not just a throughput problem. Pharmacies must rethink their strategy, not just automate it.

By Alecia Lashier

Artificial Intelligence, Health Tech, Providers

6 Ways UnityPoint Health Is Trying to Make Clinicians’ Jobs Easier

UnityPoint Health's chief medical officer, Gregory Johnson, shared several ways the system is using AI to lift administrative burden off clinicians and get them back to patient care — including ambient scribing, real-time capacity tracking and AI-powered chart review.

By Katie Adams

Payers, Health Tech

Curative, Wondr Health Team Up for Weight and Metabolic Health Support

Curative Insurance Company partnered with Wondr Health to expand weight management support for its members.

By Marissa Plescia